GJB1

Source: Wikipedia, the free encyclopedia.
GJB1
Available structures
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_000166
NM_001097642

NM_008124
NM_001302496
NM_001302497
NM_001302498

RefSeq (protein)

NP_000157
NP_001091111

NP_001289425
NP_001289426
NP_001289427
NP_032150

Location (UCSC)Chr X: 71.21 – 71.23 MbChr X: 100.42 – 100.43 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Gap junction beta-1 protein (GJB1), also known as connexin 32 (Cx32), is a

cell membranes, primarily in the liver and peripheral nervous system.[6] However, the protein is expressed in multiple organs, including in oligodendrocytes in the central nervous system.[7]

Mutations of the GJB1 gene affecting the signalling of and trafficking through gap junctions, resulting in an inherited peripheral neuropathy called X-linked

Schwann cells, causing delayed transmission rates of nerve communication in the peripheral nervous system, due to irregularities in the normal function of the cells. This condition leads to a number of symptoms, most commonly muscle weakness and sensory problems in the outer extremities of the limbs. As a result, muscle atrophy and soft tissue injuries due to delayed nerve transmission can occur. In males, due to the hemizygousity of the X-chromosome, the symptoms and issues surrounding X-linked Charcot-Marie-Tooth disease are more prevalent.[8]

Function

Connexins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells.[9] For a general discussion of connexin proteins, see GJB2.[10] In Schwann cells, GJB1 also forms channels that facilitate transfers between layers of the myelin. [11]

In melanocytic cells GJB1 gene expression may be regulated by MITF.[12]

Gene

The gene that encodes the human GJB1 protein is found on the X chromosome, on the long arm at position q13.1, in interval 8, from base pair 71,215,212 to base pair 71,225,215.[5][9]

Mutations

Approximately four hundred type X Charcot-Marie-Tooth causing

frameshift, and in-frame deletions/insertions.[6][8][9][15]
These mutations most commonly result in proteins that work incorrectly, less effectively, degrade faster, are not present in adequate numbers or may not function at all.

Structure

The GJB1 gene is approximately 10kb in length, with one coding

axons through a radial diffusion pathway.[8] As noted above, channels also form between layers of myelin. [16]

Function

GJB1 functions as a radial diffusion pathway, allowing the communication and diffusion of nutrients, ions and small molecules between cells, and between layers of myelin.

oligodendrocytes, specialised cells of the nervous system.[9][17] These cells typically encapsulate nerves and are involved in the assembly and preservation of myelin, which serves to ensure reliable and rapid transmission of nerve signals.[9][17] Typically the GJB1 protein forms channels between cells as well as through myelin to the internal Schwann cell or oligodendrocyte, allowing effective transportation and communication.[9][17]

Type X Charcot-Marie-Tooth disease

Mutations in the GJB1 gene can lead to a variety of changes in the Connexin 32 protein or its expression, as compared to the wild type gene. Pathogenic mutations in the gene affect signalling and trafficking of small molecules through gap junctions, resulting in disease - most notably an inherited peripheral neuropathy known as Charcot-Marie-Tooth disease, also often referred to as CMT. Despite the name, CMT does not affect the teeth; the word "tooth" refers to the name of one of the doctors who were important to its discovery. Because GJB1 is located on the X chromosome, GJB1 disease is a type of "X-linked" CMT. Multiple X-linked CMTs have now been identified, and GJB1 disease is referred to as CMT1X or CMTX1.

Schwann cells, causing delayed transmission rates of nerve communication in the peripheral nervous system, due to irregularities in the normal function of the cells. In addition, impact on axons has been noted, While it was originally believed that axon impact was secondary to demyelination, findings in mice suggest that axon slowing may occur independent from and precede demyelination in CMT1X, due to disturbed signalling between axons and glia as well as disturbances in glial support to axons.[19]

Unlike many other types of CMT, CMT1X is known to cause effects in the central nervous system ("CNS") as well as the peripheral nervous system.[13] However, it is believed that whether or not an individual experiences CNS effects may depend upon the specific mutation involved, and the more precise shape and function of the mutant protein in question, as some mutant GJB1 proteins have much more functionality than others.[20]

This condition leads to a number of symptoms, most commonly muscle weakness and sensory problems in the outer extremities of the limbs. As a result,

Charcot-Marie-Tooth disease are more prevalent.[8]

Approximately four hundred mutations of the GJB1 gene have been identified in people with X-linked Charcot-Marie-Tooth disease (CMTX).

hemizygous men, with the later being more severely affected.[13]

Most of the mutations of the GJB1 gene switch or change a single

Whilst CMTX is more commonly known to affect the peripheral nervous system some cases have been reported in which there is evidence of demyelination of the

nerve impulse and imaging studies, and are believed to also be caused through mutations on the GJB1 gene.[17]

Diagnosis/testing

Historically CMTX could only be diagnosed through symptoms or measurement of the speed of nerve impulses. With the creation of

genetic screening of families has also become common after the diagnosis of CMTX in a patient, to further identify other family members that may be suffering from the disease. This screening is also used systematically by researchers to identify new mutations within the gene.[6][14][15]

Management

Currently CMTX is an incurable condition, instead patients are evaluated and treated for symptoms caused by the disease. Treatment is limited to rehabilitative therapy, use of assistive devices such as

orthoses and in some cases surgical treatment of skeletal deformities and soft-tissue abnormalities.[13] Surgical treatment most commonly includes osteotomies, soft-tissue surgery (including tendon transfers) and/or joint fusions.[13]

Genetic counseling

Due to the nature of inheritance of CMTX, affected males will pass the GJB1 gene mutation to all female children and none of their male children, whilst females who are carriers will have a 50% chance of passing on the mutation to each of their offspring.

prenatal and pre-implantation testing elected by the patient, when their type of mutation has been identified.[13]
Results from genetic testing can then be used to prevent the transmission of this disease to their offspring.

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000169562Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000047797Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^
    PMID 1319395
    .
  6. ^ a b c d e Online Mendelian Inheritance in Man (OMIM): 304040
  7. PMID 19369543
    .
  8. ^ .
  9. ^ .
  10. ^ "Entrez Gene: GJB1 gap junction protein, beta 1, 32kDa".
  11. ^ Kleopa et al., How do Mutations in GJB1 Cause X-linked Charcot-Marie-Tooth Disease?, supra.
  12. PMID 19067971
    .
  13. ^ .
  14. ^ a b Takashima H, Bondurand N, Habermann H, Karadimas C, Szigeti K. "GJB1 - gap junction protein, beta 1, 32kDa, Homo sapiens". Wikigenes.
  15. ^
    S2CID 8712811
    .
  16. ^ National Library of Medicine, MedlinePlus, GJB1 Gene ("The connexin-32 protein forms channels through the myelin sheath, allowing efficient transport and communication between the outer myelin layers and the interior of the Schwann cell or oligodendrocyte."), at https://medlineplus.gov/genetics/gene/gjb1/
  17. ^ a b c d e f g h i j "GJB1 gene". Genetics Home Reference. US National Library of Medicine.
  18. ^ Muscular Dystrophy Association, "Charcot-Marie-Tooth Disease (CMT): CMTX, at https://www.mda.org/disease/charcot-marie-tooth/types/cmtx
  19. PMID 22771394
    .
  20. .

Further reading

External links

This page is based on the copyrighted Wikipedia article: GJB1. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy